DrugPatentWatch Database Preview
Patents Expiring in 2036
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dexcel Pharma | OMEPRAZOLE | omeprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 209400-001 | Jul 5, 2017 | OTC | Yes | No | Start Trial | Start Trial | Y | ||||
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | SOLUTION;INTRAVENOUS | 210632-003 | Apr 11, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | SOLUTION;INTRAVENOUS | 210632-003 | Apr 11, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | SOLUTION;INTRAVENOUS | 210632-002 | Apr 11, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | SOLUTION;INTRAVENOUS | 210632-002 | Apr 11, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | SOLUTION;INTRAVENOUS | 210632-001 | Apr 11, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
